Jun. 4 at 4:20 PM
$MIST Most of the "non-sponsored" negativity around this stock is caused by misguided expectations for the speed of commercialization. 90% of the risk has been removed, this is a great place and time to enter or build a position. Keep in mind, there's a significant number of warrants expiring in July (I believe) and that's suppressing the price for sure. The next big catalyst drops in Q3 OR Q4 when they get Medicare Part D coverage then formulary issues are much easier to navigate. There's nothing mgmt can do to speed that process other than the preparation that's been done. We have a large capable sales force creating market awareness and with each patient success that grows. This company probably gets bought between 2028 - 2030. I would guess for
$14 -
$16 a share. If that's too far off for you to yield that return, go to a casino. For the rest, stay put. Two deep breaths in followed by one long slow exhale.
